02/26/2024
8:00 AM | Theseus Pharmaceuticals (Filer)
| Form 15-12G | |
02/15/2024
11:15 PM | Theseus Pharmaceuticals (Filer)
| Form EFFECT | |
02/14/2024
1:22 PM | Theseus Pharmaceuticals (Filer)
| Form POS AM | |
02/14/2024
1:24 PM | Theseus Pharmaceuticals (Filer)
| Form S-8 POS | |
02/14/2024
1:26 PM | Theseus Pharmaceuticals (Filer)
| Form S-8 POS | |
02/14/2024
9:35 AM | Concentra Merger Sub II, Inc. (Filed by)
Theseus Pharmaceuticals (Subject)
| Form SC TO-T/A | |
02/14/2024
9:44 AM | Theseus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
02/14/2024
8:32 AM | Nasdaq Stock Market LLC (Filed by)
Theseus Pharmaceuticals (Subject)
| Form 25-NSE | |
02/13/2024
11:36 AM | Frazier Life Sciences Public Fund, L.P. (Filed by)
Theseus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/07/2024
4:15 PM | Concentra Merger Sub II, Inc. (Filed by)
Theseus Pharmaceuticals (Subject)
| Form SC TO-T/A | |
02/07/2024
4:21 PM | Theseus Pharmaceuticals (Subject)
| Form SC 14D9/A | |
01/30/2024
7:52 AM | Theseus Pharmaceuticals (Subject)
| Form SC 14D9/A | |
01/30/2024
7:23 AM | Concentra Merger Sub II, Inc. (Filed by)
Theseus Pharmaceuticals (Subject)
| Form SC TO-T/A | |
01/12/2024
5:02 AM | TANG CAPITAL PARTNERS LP (Filed by)
Theseus Pharmaceuticals (Subject)
| Form SC 13D/A | |
01/10/2024
8:47 AM | Theseus Pharmaceuticals (Subject)
| Form SC 14D9 | |
01/10/2024
7:51 AM | Concentra Merger Sub II, Inc. (Filed by)
Theseus Pharmaceuticals (Subject)
| Form SC TO-T | |
12/28/2023
5:00 AM | TANG CAPITAL PARTNERS LP (Filed by)
Theseus Pharmaceuticals (Subject)
| Form SC 13D/A | |
12/27/2023
3:43 PM | ORBIMED ADVISORS LLC (Filed by)
Theseus Pharmaceuticals (Subject)
| Form SC 13D/A | |
12/22/2023
5:52 AM | Theseus Pharmaceuticals (Subject)
| Form SC14D9C | |
12/22/2023
5:36 AM | Theseus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2023
5:30 AM | Theseus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2023
5:37 AM | Theseus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/24/2023
3:23 PM | Foresite Capital Fund V, L.P. (Filed by)
Theseus Pharmaceuticals (Subject)
| Form SC 13D/A | |
11/24/2023
3:28 PM | ORBIMED ADVISORS LLC (Filed by)
Theseus Pharmaceuticals (Subject)
| Form SC 13D/A | |
11/24/2023
12:49 PM | TANG CAPITAL PARTNERS LP (Filed by)
Theseus Pharmaceuticals (Subject)
| Form SC 13D | |
11/15/2023
6:00 AM | Theseus Pharmaceuticals (Filer)
| Form NT 10-Q | |
08/10/2023
7:19 AM | FMR LLC (Filed by)
Theseus Pharmaceuticals (Subject)
| Form SC 13G/A | |
08/10/2023
6:05 AM | Theseus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
6:06 AM | Theseus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/19/2023
3:12 PM | ORBIMED ADVISORS LLC (Filed by)
Theseus Pharmaceuticals (Subject)
| Form SC 13D/A | |
07/19/2023
3:15 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
Theseus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2023
3:17 PM | GORDON CARL L (Reporting)
Theseus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2023
1:54 PM | Foresite Capital Fund V, L.P. (Reporting)
Foresite Capital Management V, LLC (Reporting)
Foresite Capital Opportunity Fund V, L.P. (Reporting)
Foresite Capital Opportunity Management V, LLC (Reporting)
Tananbaum James B. (Reporting)
Theseus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2023
1:41 PM | Foresite Capital Fund V, L.P. (Filed by)
Theseus Pharmaceuticals (Subject)
| Form SC 13D/A | |
07/13/2023
3:08 PM | Theseus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2023
4:29 PM | GORDON CARL L (Reporting)
Theseus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
4:29 PM | HAYDEN DONALD J JR (Reporting)
Theseus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
4:30 PM | Theseus Pharmaceuticals (Issuer)
Yi Kathy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
4:30 PM | Stein Steven H (Reporting)
Theseus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
4:28 PM | Dukes Iain D. (Reporting)
Theseus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
3:32 PM | Theseus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
“Forget Tesla, this is Elon’s Next Big Thing” (Ad) According to Forbes, this breakthrough could define the future of AI.
Most people don’t know about it…
Because it was found 750 miles away from Silicon Valley. Click here to see the details. |
05/25/2023
4:04 PM | Theseus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2023
6:09 AM | Theseus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2023
6:12 AM | Theseus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2023
8:00 AM | Theseus Pharmaceuticals (Filer)
| Form DEF 14A | |
04/26/2023
8:01 AM | Theseus Pharmaceuticals (Filer)
| Form DEFA14A | |
04/26/2023
8:03 AM | Theseus Pharmaceuticals (Filer)
| Form ARS | |
